Unlocking Potential: Zentalis Pharmaceuticals Grants Inducement Awards in Compliance with Nasdaq Listing Rule 5635(c)(4)
Zentalis Pharmaceuticals Grants Stock Options to New Employees The Latest Development in the Biopharmaceutical Industry SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company, has announced that the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 16,000 shares of…